First immune-evading cells created to treat type 1 diabetes
Salk Institute scientists have made a major advance in the pursuit of a safe and effective treatment for type 1 diabetes, an illness that impacts an estimated 1.6 million Americans with a cost of $14.4 billion annually.
Aug 19, 2020
0
359
